Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Francisco, California 94117


This is a safety and efficacy study of botulinum toxin type A in subjects with primary axillary hyperhidrosis.


Inclusion Criteria: - Primary axillary hyperhidrosis - Female or male, 18 years of age or older in good general health - Excessive sweating interferes with daily life activities and scores 3 or 4 on the HDSS at Screening and Baseline - Axillary sweat production of at least 50 mg/5 min measured gravimetrically Exclusion Criteria: - Any neurological condition, that may place the subject at increased risk with exposure to botulinum toxin type A such as amyotrophic lateral sclerosis and motor neuropathy, Lambert-Eaton syndrome, and Myasthenia gravis - Muscle weakness or paralysis, particularly in the upper extremities - Active skin disease or irritation or disrupted barrier at the treatment area - Undergone any procedures which may affect the axillary areas - Treatment with botulinum toxin type A in the axilla in the last 9 months or anywhere in the body in the last 6 months - Any prior axillary use of an anti-hyperhidrosis medical device - If menopausal had symptoms of menopause such as sweating or flushing within the last year



Primary Contact:


Backup Contact:


Location Contact:

San Francisco, California 94117
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.